{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T10:36:38Z","timestamp":1760524598460,"version":"3.37.3"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,3,21]],"date-time":"2024-03-21T00:00:00Z","timestamp":1710979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,3,21]],"date-time":"2024-03-21T00:00:00Z","timestamp":1710979200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100005743","name":"Universit\u00e0 Cattolica del Sacro Cuore","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005743","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Radiol med"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Objectives<\/jats:title>\n                <jats:p>Combined treatment of ablation and chemoembolization for hepatocellular carcinoma represents a promising therapy to increase treatment efficacy and improve patient survival. The \u201chug sign\u201d is a recently introduced radiological sign consisting in deposition of beads\/contrast agent during transarterial chemoembolization in the hyperemic area surrounding the post-ablation volume, seen during intraprocedural unenhanced cone-beam CT, that may indicate intraprocedural success. Aim of our retrospective study was to analyze the usefulness of the \u201chug sign\u201d at the intraprocedural unenhanced cone-beam CT as an early predictor of response to combined treatment, based on the hug sign angle.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Materials and methods<\/jats:title>\n                <jats:p>Between January 2017 and September 2021 all patients with hepatocellular carcinoma which underwent a combined treatment of thermal ablation followed by chemoembolization were enrolled. All treated patients underwent immediate post-procedural unenhanced cone-beam CT to evaluate the deposition of contrast agent, lipiodol or radiopaque beads and to assess the percentage of coverage of the ablated area with the contrast agent (hug sign angle). Patients with missing pre-procedural, intra-procedural and\/or post-procedural data\/imaging, or with poor-quality post-procedural cone-beam CT images were excluded.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>128 patients (mean age, 69.3\u00a0years\u2009\u00b1\u20091.1 [standard deviation]; 87 men) were evaluated. Our study evidenced that 84.4% (81\/85) of patients with a hug sign angle of 360\u00b0 had no residual tumor at the first 1-\/3-months follow-up examination. A hug sign angle of 360\u00b0 also showed to be an independent protective factor against residual tumor at multivariate analysis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Unenhanced cone-beam CT performed at the end of a combined treatment with ablation plus chemoembolization can effectively predict an early treatment response on radiological images, when a hug sign angle of 360\u00b0 was detected.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s11547-024-01805-y","type":"journal-article","created":{"date-parts":[[2024,3,21]],"date-time":"2024-03-21T12:02:07Z","timestamp":1711022527000},"page":"807-816","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Hug sign in intraprocedural cone-beam-CT to predict short-term response to combined treatment of hepatocellular carcinoma"],"prefix":"10.1007","volume":"129","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2791-481X","authenticated-orcid":false,"given":"Roberto","family":"Iezzi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandro","family":"Posa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iacopo","family":"Valente","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Contegiacomo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Assunta","family":"Zocco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maurizio","family":"Pompili","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brigida Eleonora","family":"Annicchiarico","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca Romana","family":"Ponziani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michele","family":"Basso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shraga Nahum","family":"Goldberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felice","family":"Giuliante","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Gasbarrini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evis","family":"Sala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"HepatoCatt Study Group","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enza","family":"Genco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriella","family":"Brizi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Cellini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Riccardi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicoletta","family":"De Matthaeis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Biolato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luca","family":"Miele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucia","family":"Cerrito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabrizio","family":"Pizzolante","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Grieco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gian Ludovico","family":"Rapaccini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Marrone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matteo","family":"Garcovich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alfonso Wolfango","family":"Avolio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Ardito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriele","family":"Spoletini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salvatore","family":"Agnes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Vellone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,3,21]]},"reference":[{"key":"1805_CR1","doi-asserted-by":"publisher","unstructured":"European Association For The Study Of The Liver; European Organisation for Research and Treatment Of Cancer (2012) EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol 56:908\u2013943https:\/\/doi.org\/10.1016\/j.jhep.2011.12.001. Erratum in: (2012) J Hepatol 56:1430","DOI":"10.1016\/j.jhep.2011.12.001"},{"key":"1805_CR2","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1002\/hep.23485","volume":"51","author":"G Cabibbo","year":"2010","unstructured":"Cabibbo G, Enea M, Attanasio M, Bruix J, Crax\u00ec A, Camm\u00e0 C (2010) A meta-analysis of survival rates of untreated patients in randomized clinical trials of hepatocellular carcinoma. Hepatology 51:1274\u20131283. https:\/\/doi.org\/10.1002\/hep.23485","journal-title":"Hepatology"},{"key":"1805_CR3","doi-asserted-by":"publisher","unstructured":"Llovet JM, Ricci S, Mazzaferro V, Hilgard P, Gane E, Blanc JF, de Oliveira AC, Santoro A, Raoul JL, Forner A, Schwartz M, Porta C, Zeuzem S, Bolondi L, Greten TF, Galle PR, Seitz JF, Borbath I, H\u00e4ussinger D, Giannaris T, Shan M, Moscovici M, Voliotis D, Bruix J, SHARP Investigators Study Group (2008) Sorafenib in advanced hepatocellular carcinoma. N Engl J Med 359:378\u2013390https:\/\/doi.org\/10.1056\/NEJMoa0708857","DOI":"10.1056\/NEJMoa0708857"},{"key":"1805_CR4","doi-asserted-by":"publisher","first-page":"589","DOI":"10.5114\/jcb.2019.90466","volume":"11","author":"A Kov\u00e1cs","year":"2019","unstructured":"Kov\u00e1cs A, Iezzi R, Cellini F, Lancellotta V, Bischoff P, Carchesio F, Tagliaferri L, Kov\u00e1cs G, Gambacorta MA (2019) Critical review of multidisciplinary non-surgical local interventional ablation techniques in primary or secondary liver malignancies. J Contemp Brachytherapy 11:589\u2013600. https:\/\/doi.org\/10.5114\/jcb.2019.90466","journal-title":"J Contemp Brachytherapy"},{"key":"1805_CR5","doi-asserted-by":"publisher","first-page":"1935","DOI":"10.3748\/wjg.v22.i6.1935","volume":"22","author":"R Iezzi","year":"2016","unstructured":"Iezzi R, Pompili M, Posa A, Coppola G, Gasbarrini A, Bonomo L (2016) Combined locoregional treatment of patients with hepatocellular carcinoma: State of the art. World J Gastroenterol 22:1935\u20131942. https:\/\/doi.org\/10.3748\/wjg.v22.i6.1935","journal-title":"World J Gastroenterol"},{"key":"1805_CR6","doi-asserted-by":"publisher","first-page":"180","DOI":"10.3390\/life10090180","volume":"10","author":"R Iezzi","year":"2020","unstructured":"Iezzi R, Bilhim T, Crocetti L, Peynircioglu B, Goldberg S, Bilbao JI, Sami A, Akhan O, Scalise P, Giuliante F, Pompili M, Valentini V, Gasbarrini A, Colosimo C, Manfredi R (2020) \u201cPrimum non nocere\u201d in interventional oncology for liver cancer: how to reduce the risk for complications? Life (Basel) 10:180. https:\/\/doi.org\/10.3390\/life10090180","journal-title":"Life (Basel)"},{"key":"1805_CR7","doi-asserted-by":"publisher","unstructured":"Iezzi R, Pompili M, Posa A, Carchesio F, Siciliano M, Annicchiarico BE, Agnes S, Giuliante F, Garcovich M, Cerrito L, Ponziani FR, Basso M, Cassano A, Rapaccini GL, De Gaetano AM, Gasbarrini A, Manfredi R, HepatoCATT Study Group for the Multidisciplinary Management of HCC (2019) Interventional oncology treatments for unresectable early stage HCC in patients with a high risk for intraprocedural bleeding: Is a single-step combined therapy safe and feasible? Eur J Radiol 114:32\u201337https:\/\/doi.org\/10.1016\/j.ejrad.2019.02.030","DOI":"10.1016\/j.ejrad.2019.02.030"},{"key":"1805_CR8","doi-asserted-by":"publisher","unstructured":"Iezzi R, Pompili M, La Torre MF, Campanale MC, Montagna M, Saviano A, Cesario V, Siciliano M, Annicchiarico E, Agnes S, Giuliante F, Grieco A, Rapaccini GL, De Gaetano AM, Gasbarrini A, Bonomo L, HepatoCATT Study Group for the Multidisciplinary Management of HCC (2015) Radiofrequency ablation plus drug-eluting beads transcatheter arterial chemoembolization for the treatment of single large hepatocellular carcinoma. Dig Liver Dis 47:242\u2013248https:\/\/doi.org\/10.1016\/j.dld.2014.12.007","DOI":"10.1016\/j.dld.2014.12.007"},{"key":"1805_CR9","doi-asserted-by":"publisher","unstructured":"Saviano A, Iezzi R, Giuliante F, Salvatore L, Mele C, Posa A, Ardito F, De Gaetano AM, Pompili M, HepatoCATT Study Group (2017) Liver resection versus radiofrequency ablation plus transcatheter arterial chemoembolization in cirrhotic patients with solitary large hepatocellular carcinoma. J Vasc Interv Radiol 28:1512\u20131519https:\/\/doi.org\/10.1016\/j.jvir.2017.06.016","DOI":"10.1016\/j.jvir.2017.06.016"},{"key":"1805_CR10","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1148\/radiol.14131311","volume":"272","author":"D Wang","year":"2014","unstructured":"Wang D, Gaba RC, Jin B, Lewandowski RJ, Riaz A, Memon K, Ryu RK, Sato KT, Kulik LM, Mulcahy MF, Larson AC, Salem R, Omary RA (2014) Perfusion reduction at transcatheter intraarterial perfusion MR imaging: a promising intraprocedural biomarker to predict transplant-free survival during chemoembolization of hepatocellular carcinoma. Radiology 272:587\u2013597. https:\/\/doi.org\/10.1148\/radiol.14131311","journal-title":"Radiology"},{"key":"1805_CR11","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s13027-021-00393-0","volume":"16","author":"V Granata","year":"2021","unstructured":"Granata V, Grassi R, Fusco R, Belli A, Cutolo C, Pradella S, Grazzini G, La Porta M, Brunese MC, De Muzio F, Ottaiano A, Avallone A, Izzo F, Petrillo A (2021) Diagnostic evaluation and ablation treatments assessment in hepatocellular carcinoma. Infect Agent Cancer 16:53. https:\/\/doi.org\/10.1186\/s13027-021-00393-0","journal-title":"Infect Agent Cancer"},{"key":"1805_CR12","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.clon.2007.11.011","volume":"20","author":"H Kuehl","year":"2008","unstructured":"Kuehl H, Stattaus J, Hertel S, Hunold P, Kaiser G, Bockisch A, Forsting M (2008) Mid-term outcome of positron emission tomography\/computed tomography-assisted radiofrequency ablation in primary and secondary liver tumors\u2013a single-center experience. Clin Oncol (R Coll Radiol) 20:234\u2013240. https:\/\/doi.org\/10.1016\/j.clon.2007.11.011","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"1805_CR13","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1055\/s-0034-1373793","volume":"31","author":"ED McLoney","year":"2014","unstructured":"McLoney ED, Isaacson AJ, Keating P (2014) The role of PET imaging before, during, and after percutaneous hepatic and pulmonary tumor ablation. Semin Intervent Radiol 31:187\u2013192. https:\/\/doi.org\/10.1055\/s-0034-1373793","journal-title":"Semin Intervent Radiol"},{"key":"1805_CR14","doi-asserted-by":"publisher","first-page":"8856998","DOI":"10.1155\/2021\/8856998","volume":"2021","author":"A Orlacchio","year":"2021","unstructured":"Orlacchio A, Roma S, dell\u2019Olio V, Crociati S, Lenci I, Francioso S (2021) Role of cone-beam CT in the intraprocedural evaluation of chemoembolization of hepatocellular carcinoma. J Oncol 2021:8856998. https:\/\/doi.org\/10.1155\/2021\/8856998","journal-title":"J Oncol"},{"key":"1805_CR15","doi-asserted-by":"publisher","first-page":"7089","DOI":"10.3390\/jcm11237089","volume":"11","author":"M Fronda","year":"2022","unstructured":"Fronda M, Mistretta F, Calandri M, Ciferri F, Nardelli F, Bergamasco L, Fonio P, Doriguzzi Breatta A (2022) The role of immediate post-procedural cone-beam computed tomography (CBCT) in predicting the early radiologic response of hepatocellular carcinoma (HCC) nodules to drug-eluting bead transarterial chemoembolization (DEB-TACE). J Clin Med 11:7089. https:\/\/doi.org\/10.3390\/jcm11237089","journal-title":"J Clin Med"},{"key":"1805_CR16","doi-asserted-by":"publisher","first-page":"69","DOI":"10.2217\/hep-2017-0017.Erratum.In:(2018)HepatOncol7:1","volume":"4","author":"R Iezzi","year":"2018","unstructured":"Iezzi R, Pompili M, Annicchiarico EB, Garcovich M, Siciliano M, Gasbarrini A, Manfredi R (2018) \u201cHug sign\u201d: a new radiological sign of intraprocedural success after combined treatment for hepatocellular carcinoma. Hepat Oncol 4:69\u201373. https:\/\/doi.org\/10.2217\/hep-2017-0017.Erratum.In:(2018)HepatOncol7:1","journal-title":"Hepat Oncol"},{"key":"1805_CR17","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1016\/s0022-5347(17)38508-7","volume":"145","author":"MK Terris","year":"1991","unstructured":"Terris MK, Stamey TA (1991) Determination of prostate volume by transrectal ultrasound. J Urol 145:984\u2013987. https:\/\/doi.org\/10.1016\/s0022-5347(17)38508-7","journal-title":"J Urol"},{"key":"1805_CR18","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1055\/s-0030-1247132","volume":"30","author":"R Lencioni","year":"2010","unstructured":"Lencioni R, Llovet JM (2010) Modified RECIST (mRECIST) assessment for hepatocellular carcinoma. Semin Liver Dis 30:52\u201360. https:\/\/doi.org\/10.1055\/s-0030-1247132","journal-title":"Semin Liver Dis"},{"key":"1805_CR19","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1007\/s00270-017-1703-4","volume":"40","author":"DK Filippiadis","year":"2017","unstructured":"Filippiadis DK, Binkert C, Pellerin O, Hoffmann RT, Krajina A, Pereira PL (2017) Cirse quality assurance document and standards for classification of complications: the cirse classification system. Cardiovasc Intervent Radiol 40:1141\u20131146. https:\/\/doi.org\/10.1007\/s00270-017-1703-4","journal-title":"Cardiovasc Intervent Radiol"},{"key":"1805_CR20","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1186\/s12876-021-01765-x","volume":"21","author":"L Yan","year":"2021","unstructured":"Yan L, Ren Y, Qian K, Kan X, Zhang H, Chen L, Liang B, Zheng C (2021) Sequential transarterial chemoembolization and early radiofrequency ablation improves clinical outcomes for early-intermediate hepatocellular carcinoma in a 10-year single-center comparative study. BMC Gastroenterol 21:182. https:\/\/doi.org\/10.1186\/s12876-021-01765-x","journal-title":"BMC Gastroenterol"},{"key":"1805_CR21","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1097\/MEG.0b013e32835a0a07","volume":"25","author":"Z Lu","year":"2013","unstructured":"Lu Z, Wen F, Guo Q, Liang H, Mao X, Sun H (2013) Radiofrequency ablation plus chemoembolization versus radiofrequency ablation alone for hepatocellular carcinoma: a meta-analysis of randomized-controlled trials. Eur J Gastroenterol Hepatol 25:187\u2013194. https:\/\/doi.org\/10.1097\/MEG.0b013e32835a0a07","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"1805_CR22","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1080\/02656736.2021.1887941","volume":"38","author":"MMA Zaitoun","year":"2021","unstructured":"Zaitoun MMA, Elsayed SB, Zaitoun NA, Soliman RK, Elmokadem AH, Farag AA, Amer M, Hendi AM, Mahmoud NEM, Salah El Deen D, Alsowey AM, Shahin S, Basha MAA (2021) Combined therapy with conventional trans-arterial chemoembolization (cTACE) and microwave ablation (MWA) for hepatocellular carcinoma >3-<5 cm. Int J Hyperth 38:248\u2013256. https:\/\/doi.org\/10.1080\/02656736.2021.1887941","journal-title":"Int J Hyperth"},{"key":"1805_CR23","doi-asserted-by":"publisher","first-page":"e189","DOI":"10.1016\/j.ejrad.2011.01.122","volume":"81","author":"JW Kim","year":"2012","unstructured":"Kim JW, Kim JH, Won HJ, Shin YM, Yoon HK, Sung KB, Kim PN (2012) Hepatocellular carcinomas 2\u20133 cm in diameter: transarterial chemoembolization plus radiofrequency ablation vs. radiofrequency ablation alone. Eur J Radiol 81:e189\u2013e193. https:\/\/doi.org\/10.1016\/j.ejrad.2011.01.122","journal-title":"Eur J Radiol"},{"key":"1805_CR24","doi-asserted-by":"publisher","first-page":"167","DOI":"10.4166\/kjg.2019.73.3.167","volume":"73","author":"AR Kim","year":"2019","unstructured":"Kim AR, Park E, Kwon SY, Park SJ, Kim YJ, Yoo BC, Choe WH, Kim JH, Hwang JH, Park SW, Kim YJ, Park HS, Yu MH, Jeon HJ (2019) Efficacy and safety of combined radiofrequency ablation with transarterial chemoembolization in patients with barcelona clinic liver cancer stage a hepatocellular carcinoma ineligible for curative treatment. Korean J Gastroenterol 73:167\u2013176. https:\/\/doi.org\/10.4166\/kjg.2019.73.3.167","journal-title":"Korean J Gastroenterol"},{"key":"1805_CR25","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.21037\/tcr-22-816","volume":"11","author":"Y Yu","year":"2022","unstructured":"Yu Y, Fu J, Xia P, Chu C (2022) A systematic review and meta-analysis on the efficacy and safety of transcatheter arterial chemoembolization combined with radiofrequency ablation in the treatment of primary liver cancer. Transl Cancer Res 11:1297\u20131308. https:\/\/doi.org\/10.21037\/tcr-22-816","journal-title":"Transl Cancer Res"},{"key":"1805_CR26","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1245\/s10434-007-9733-9","volume":"15","author":"VW Lam","year":"2008","unstructured":"Lam VW, Ng KK, Chok KS, Cheung TT, Yuen J, Tung H, Tso WK, Fan ST, Poon RT (2008) Incomplete ablation after radiofrequency ablation of hepatocellular carcinoma: analysis of risk factors and prognostic factors. Ann Surg Oncol 15:782\u2013790. https:\/\/doi.org\/10.1245\/s10434-007-9733-9","journal-title":"Ann Surg Oncol"},{"key":"1805_CR27","first-page":"430","volume":"95","author":"T Siriapisith","year":"2012","unstructured":"Siriapisith T, Siwasattayanon P, Tongdee T (2012) Radiofrequency ablation alone versus radiofrequency ablation combined with chemoembolization in unresectable hepatocellular carcinoma. J Med Assoc Thai 95:430\u2013436","journal-title":"J Med Assoc Thai"},{"key":"1805_CR28","doi-asserted-by":"publisher","first-page":"e990","DOI":"10.1634\/theoncologist.2018-0337","volume":"24","author":"F Izzo","year":"2019","unstructured":"Izzo F, Granata V, Grassi R, Fusco R, Palaia R, Delrio P, Carrafiello G, Azoulay D, Petrillo A, Curley SA (2019) Radiofrequency ablation and microwave ablation in liver tumors: an update. Oncologist 24:e990\u2013e1005. https:\/\/doi.org\/10.1634\/theoncologist.2018-0337","journal-title":"Oncologist"},{"key":"1805_CR29","doi-asserted-by":"publisher","first-page":"2736","DOI":"10.1007\/s00261-020-02612-5","volume":"45","author":"J Long","year":"2020","unstructured":"Long J, Wang H, Zhao P, Sheng SP, Qin-Sheng S, Long M, Zheng JS (2020) Transarterial chemoembolization combined with radiofrequency ablation for solitary large hepatocellular carcinoma ranging from 5 to 7 cm: an 8-year prospective study. Abdom Radiol 45:2736\u20132747. https:\/\/doi.org\/10.1007\/s00261-020-02612-5","journal-title":"Abdom Radiol"},{"key":"1805_CR30","doi-asserted-by":"publisher","first-page":"298","DOI":"10.21037\/jgo.2019.01.07","volume":"11","author":"R Yamada","year":"2020","unstructured":"Yamada R, Bassaco B, Bracewell S, Volin S, Collins H, Hannegan C, Guimaraes M (2020) Combined conventional transarterial chemoembolization with mitomycin and percutaneous ablation for unresectable hepatocellular carcinoma. J Gastrointest Oncol 11:298\u2013303. https:\/\/doi.org\/10.21037\/jgo.2019.01.07","journal-title":"J Gastrointest Oncol"},{"key":"1805_CR31","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1007\/s00270-021-02858-6","volume":"44","author":"C Ruff","year":"2021","unstructured":"Ruff C, Artzner C, Syha R, Grosse U, Hoffmann R, Bitzer M, Partovi S, Horger M, Nikolaou K, Gr\u00f6zinger G (2021) Transarterial chemoembolization of hepatocellular carcinoma using radiopaque drug-eluting embolics: impact of embolic density and residual tumor perfusion on tumor recurrence and survival. Cardiovasc Intervent Radiol 44:1403\u20131413. https:\/\/doi.org\/10.1007\/s00270-021-02858-6","journal-title":"Cardiovasc Intervent Radiol"}],"container-title":["La radiologia medica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11547-024-01805-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11547-024-01805-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11547-024-01805-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,11]],"date-time":"2024-05-11T10:14:12Z","timestamp":1715422452000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11547-024-01805-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,21]]},"references-count":31,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2024,5]]}},"alternative-id":["1805"],"URL":"https:\/\/doi.org\/10.1007\/s11547-024-01805-y","relation":{},"ISSN":["1826-6983"],"issn-type":[{"type":"electronic","value":"1826-6983"}],"subject":[],"published":{"date-parts":[[2024,3,21]]},"assertion":[{"value":"21 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by the Institutional Review Board and was performed in agreement with the 1990 Declaration of Helsinki and subsequent amendments. Due to the retrospective nature of the study, the Research Ethics Committee has confirmed that no ethical approval is required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Due to the retrospective nature of the study informed consent to participation was waived by the Ethics Committee.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}]}}